Dermatology

Cardiovascular disease

Questions discussed in this category

What is your approach to management of hyperlipidemia in patients taking JAK inhibitors?

1 Answer available

Papers discussed in this category

N Engl J Med,

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.

Autoimmunity reviews, 2023 Dec 20

Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study.

Related Topics in Dermatology